» Articles » PMID: 38133457

Glucose-mediated Mitochondrial Reprogramming by Cholesterol Export at TM4SF5-enriched Mitochondria-lysosome Contact Sites

Abstract

Background: Transmembrane 4 L six family member 5 (TM4SF5) translocates subcellularly and functions metabolically, although it is unclear how intracellular TM4SF5 translocation is linked to metabolic contexts. It is thus of interests to understand how the traffic dynamics of TM4SF5 to subcellular endosomal membranes are correlated to regulatory roles of metabolisms.

Methods: Here, we explored the metabolic significance of TM4SF5 localization at mitochondria-lysosome contact sites (MLCSs), using in vitro cells and in vivo animal systems, via approaches by immunofluorescence, proximity labelling based proteomics analysis, organelle reconstitution etc. RESULTS: Upon extracellular glucose repletion following depletion, TM4SF5 became enriched at MLCSs via an interaction between mitochondrial FK506-binding protein 8 (FKBP8) and lysosomal TM4SF5. Proximity labeling showed molecular clustering of phospho-dynamic-related protein I (DRP1) and certain mitophagy receptors at TM4SF5-enriched MLCSs, leading to mitochondrial fission and autophagy. TM4SF5 bound NPC intracellular cholesterol transporter 1 (NPC1) and free cholesterol, and mediated export of lysosomal cholesterol to mitochondria, leading to impaired oxidative phosphorylation but intact tricarboxylic acid (TCA) cycle and β-oxidation. In mouse models, hepatocyte Tm4sf5 promoted mitophagy and cholesterol transport to mitochondria, both with positive relations to liver malignancy.

Conclusions: Our findings suggested that TM4SF5-enriched MLCSs regulate glucose catabolism by facilitating cholesterol export for mitochondrial reprogramming, presumably while hepatocellular carcinogenesis, recapitulating aspects for hepatocellular carcinoma metabolism with mitochondrial reprogramming to support biomolecule synthesis in addition to glycolytic energetics.

Citing Articles

Novel strategies targeting mitochondria-lysosome contact sites for the treatment of neurological diseases.

Xie Y, Sun W, Han A, Zhou X, Zhang S, Shen C Front Mol Neurosci. 2025; 17:1527013.

PMID: 39877141 PMC: 11772484. DOI: 10.3389/fnmol.2024.1527013.


Isoxazole-based molecules restore NK cell immune surveillance in hepatocarcinogenesis by targeting TM4SF5 and SLAMF7 linkage.

Kim J, Kim H, Kim W, Lee E, Kim S, Kim T Signal Transduct Target Ther. 2025; 10(1):15.

PMID: 39828766 PMC: 11743776. DOI: 10.1038/s41392-024-02106-6.


Precision proteomics with TurboID: mapping the suborganelle landscape.

Kim H, Kim K Korean J Physiol Pharmacol. 2024; 28(6):495-501.

PMID: 39467713 PMC: 11519719. DOI: 10.4196/kjpp.2024.28.6.495.


A new perspective on the regulation of glucose and cholesterol transport by mitochondria-lysosome contact sites.

Chen X, Li C, Zhou X, Zhu M, Jin J, Wang P Front Physiol. 2024; 15:1431030.

PMID: 39290619 PMC: 11405319. DOI: 10.3389/fphys.2024.1431030.


Glucose-mediated mitochondrial reprogramming by cholesterol export at TM4SF5-enriched mitochondria-lysosome contact sites.

Kim J, Park S, Kwak C, Lee Y, Song D, Jung J Cancer Commun (Lond). 2023; 44(1):47-75.

PMID: 38133457 PMC: 10794009. DOI: 10.1002/cac2.12510.

References
1.
Herrera-Cruz M, Simmen T . Over Six Decades of Discovery and Characterization of the Architecture at Mitochondria-Associated Membranes (MAMs). Adv Exp Med Biol. 2017; 997:13-31. DOI: 10.1007/978-981-10-4567-7_2. View

2.
Yoo S, Yamashita S, Kim H, Na D, Lee H, Kim S . FKBP8 LIRL-dependent mitochondrial fragmentation facilitates mitophagy under stress conditions. FASEB J. 2020; 34(2):2944-2957. DOI: 10.1096/fj.201901735R. View

3.
Jung J, Kim J, Kim E, Lee H, Lee H, Shin E . Liver-originated small extracellular vesicles with TM4SF5 target brown adipose tissue for homeostatic glucose clearance. J Extracell Vesicles. 2022; 11(9):e12262. PMC: 9443943. DOI: 10.1002/jev2.12262. View

4.
Matyash V, Liebisch G, Kurzchalia T, Shevchenko A, Schwudke D . Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. J Lipid Res. 2008; 49(5):1137-46. PMC: 2311442. DOI: 10.1194/jlr.D700041-JLR200. View

5.
Lee S, Ryu H, Kim Y, Choi S, Lee M, Kwak T . Blockade of four-transmembrane L6 family member 5 (TM4SF5)-mediated tumorigenicity in hepatocytes by a synthetic chalcone derivative. Hepatology. 2009; 49(4):1316-25. DOI: 10.1002/hep.22777. View